Loss of CDKN2A and CDKN2B expression is associated with disease recurrence in oral cancer

Conclusion: CDKN2A and CDKN2B expression analysis can be used as the prognostic marker for the oral cancer patients. The present method of data analysis helps overcome the limitations and complications of high throughput techniques and thereby increases the opportunity of employing molecular markers in routine clinical management of OSCC.

Source: Journal of Oral and Maxillofacial Pathology - April 16, 2019 Category: ENT & OMF Authors: VG Deepak Roshan MS Sinto Bipin T Vargees S Kannan Source Type: research